Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03526341 · ClinicalTrials.gov registry record
Post Market Clinical Follow Up Study for ReliaTack™ Articulating Reloadable Fixation Device With Deep Purchase Tacks
A clinical trial, sponsored by Medtronic - MITG.
- Completed
- Registry status
- 116
- Enrollment target
NCT03526341 is a clinical trial that has completed, run by Medtronic - MITG. The registered enrollment target is 116 participants.
The verdict
NCT03526341 has completed, sponsored by Medtronic - MITG.
- COMPLETED
- Registry status
- 116 participants
- Enrollment target
Study Summary
A post-market clinical follow-up study for ReliaTack™ articulating reloadable fixation device with deep purchase tacks
Interventions
- DEVICE ReliaTack™ Articulating Reloadable Fixation Device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 116 participants |
| Start Date | 2018-04-25 |
| Est. Completion | 2019-09-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03526341
The ClinicalTrials.gov registry entry for NCT03526341 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 116 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic - MITG, which has 119 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ReliaTack™ Articulating Reloadable Fixation Device is the first listed.
NCT03526341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03526341 about?
NCT03526341 is a clinical study titled "Post Market Clinical Follow Up Study for ReliaTack™ Articulating Reloadable Fixation Device With Deep Purchase Tacks". A post-market clinical follow-up study for ReliaTack™ articulating reloadable fixation device with deep purchase tacks
What is the current status of trial NCT03526341?
This trial is currently completed. The enrollment target is 116 participants. The study started on 2018-04-25. Estimated completion is 2019-09-10.
What interventions are being tested in trial NCT03526341?
The interventions under investigation include: ReliaTack™ Articulating Reloadable Fixation Device (DEVICE).
Who is sponsoring clinical trial NCT03526341?
This trial is sponsored by Medtronic - MITG, which has 119 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.